Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Researchers have uncovered a specific form of epigenetic aging that leads to the shutdown of key genes in intestinal stem ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, Germany, the Molecular Biotechnology ...

Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, ...

Laigo Bio’s SureTAC™ membrane protein degradation technology targets key signaling molecules in autoimmune, graft rejection, and oncology UTRECHT, the Netherlands - 4 December 2025 (08:30 CET). Laigo ...

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

A study from the Hospital del Mar Research Institute, published in The Journal of Clinical Investigation, indicates that the high expression of the estrogen receptor is the main factor preventing the ...